Study of Ibrutinib in Combination With Pomalidomide and Dexamethasone in Subjects With Relapsed/Refractory Multiple Myeloma

Name: Study of Ibrutinib in Combination With Pomalidomide and Dexamethasone in Subjects With Relapsed/Refractory Multiple Myeloma
Published: 2016
License: Public Domain

Pharmacyclics LLC. · 2016

ClinicalTrials.gov · Datasets · License: Public Domain · 2016

Open Source ↗

multiple-myeloma

multiple myeloma, bruton's tyrosine kinase, pci-32765, pomalidomide, dexamethasone, relapsed refractory multiple myeloma, ibrutinib, interventional, phase1, phase2

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Study of Ibrutinib in Combination With Pomalidomide and Dexamethasone in Subjects With Relapsed/Refractory Multiple Myeloma

Related documents